Novelion Therapeutics (NVLN) Form 4 QLT / Jeffrey A Meckler ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Meckler Jeffrey A

(Last) (First) (Middle)

C/O QLT INC.

887 GREAT NORTHERN WAY, SUITE 250

(Street)

VANCOUVER A1 V5T 4T5

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QLT INC/BC [ QLTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2015

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	06/29/2015		M		12,500	A	$3.67(1)	94,500	D
Common Shares	06/29/2015		M		12,500	A	$3.3(2)	107,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$3.67(1)	06/29/2015		M			12,500	(3)	07/15/2023	Common Shares	12,500	$0	0	D
Stock Option (right to buy)	$3.3(2)	06/29/2015		M			12,500	(4)	12/17/2024	Common Shares	12,500	$0	0	D

Explanation of Responses:

1. Price reflects the conversion of Canadian dollars to US dollars based on the exchange rate in effect as of the date of the reportable event. The option exercise price is CAD $4.54 per share, which was the closing price of the Issuer's common stock on the Toronto Stock Exchange as of the date of grant.

2. Price reflects the conversion of Canadian dollars to US dollars based on the exchange rate in effect as of the date of the reportable event. The option exercise price is CAD $4.08 per share, which was the closing price of the Issuer's common stock on the Toronto Stock Exchange as of the date of grant.

3. The options were scheduled to vest and become exercisable in thirty-six (36) successive and equal monthly installments beginning on the one-month anniversary of the date of grant (or August 15, 2013), such that 100% of the options would be fully vested on July 15, 2016. On June 7, 2015, the Board of Directors of QLT approved the immediate vesting of all stock options held by the Reporting Person.

4. The options were scheduled to vest and become exercisable in thirty-six (36) successive and equal monthly installments beginning on the one-month anniversary of the date of grant (or January 17, 2015), such that 100% of the options would be fully vested on December 17, 2017. On June 7, 2015, the Board of Directors of QLT approved the immediate vesting of all stock options held by the Reporting Person.

Remarks:

	Dori Assaly, as Attorney-in-Fact	07/01/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.